Search - tctmd.com

Displaying 401 - 420 of 874

Sort: Relevancy | Date

Presentation TCT 2020

TCT 573: The First Case of Impella RP Use in Acute Right Ventricular Failure From Air Embolism

Presenter: Yaser Khalid

October 14, 2020

Presentation TCT 2020

TCT 114: Impact of Annular Size and Valve Type on Hemodynamics and Clinical Outcomes after TAVR

Presenter: Steven Russo

October 14, 2020

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

L.A. McKeown

October 12, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Conference News ESC 2020

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Michael O'Riordan

August 29, 2020

News Daily News

ECMO in AMICS: Amid Few Prospective Trials, a Multicenter Registry Yields Insights

Caitlin E. Cox

August 18, 2020

News Opinion Fellow Talk

I Made It! 10 Ways to Make the Most of Your Interventional Cardiology Fellowship

Jay Mohan, DO

August 12, 2020

News Daily News

Higher BP May Limit Myocardial Injury in AMICS

Caitlin E. Cox

August 10, 2020

News Daily News

Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats

Todd Neale

July 31, 2020

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Daily News

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

L.A. McKeown

July 23, 2020

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

News Conference News EuroPCR 2020

‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry

Yael L. Maxwell

July 01, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Conference News HRS 2020

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Michael O'Riordan

May 21, 2020

News Daily News

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

Todd Neale

April 29, 2020

News Features

Thanks to COVID-19, Cardiology Fellows Gain Unexpected Skills but Risk Losing Others

Yael L. Maxwell

April 16, 2020

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

Advertisement

TCT 573: The First Case of Impella RP Use in Acute Right Ventricular Failure From Air Embolism

TCT 114: Impact of Annular Size and Valve Type on Hemodynamics and Clinical Outcomes after TAVR

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

Which TAVR Device Is Best? Review Tackles Optimal Selection

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

ECMO in AMICS: Amid Few Prospective Trials, a Multicenter Registry Yields Insights

I Made It! 10 Ways to Make the Most of Your Interventional Cardiology Fellowship

Higher BP May Limit Myocardial Injury in AMICS

Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

‘Suboptimal’ Outcomes in Real-world Mitral Valve-in-Valve, Valve-in-Ring: VIVID Registry

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

Thanks to COVID-19, Cardiology Fellows Gain Unexpected Skills but Risk Losing Others

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content